Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Pharmaceutical

Daiichi Sankyo

Ken Keller

Xin Ye

Lerryn Trzcinski

Brian Hauser

James Felix

Rich Jones

Mila Tartakovsky

Patricia A. Barbieri

Atsushi Tsukamoto

Fussy Tracy

Kevin R Forrest

Matt Siegel

Martin Unverdorben

Michael Grosso

Mary Pinder-Schenck

Barry Fortner

Daniel Switzer

Kevin Smith

Dale E. Shuster

Lin Zhang

Stu Mackey

Scott Cleve

Michele Schmidt

Barbara Tantillo Rn Bsn

Raquel Coca Lopez

Simon King

Kara Reheis

Hayes Williams

Ken Takeshita

Daiichi Sankyo's CEO and Executive Team includes Ken Keller.

CEO and Executive Team

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Daiichi Sankyo

Leadership Team